MLM
45
-5
A
37
-2
HRB
59
2
TSN
50
-2
GE
61
-3
PCAR
56
-5
FFIV
66
-4
NVDA
52
-5
HUM
41
-4
F
56
-3
PEP
39
-9
MUR
44
-3
WEC
53
5
TDC
67
-4
HPE
44
-2
GS
72
4
ROST
57
-3
STI
45
26
CVS
41
-4
ECL
55
-2
MLM
45
-5
A
37
-2
HRB
59
2
TSN
50
-2
GE
61
-3
PCAR
56
-5
FFIV
66
-4
NVDA
52
-5
HUM
41
-4
F
56
-3
PEP
39
-9
MUR
44
-3
WEC
53
5
TDC
67
-4
HPE
44
-2
GS
72
4
ROST
57
-3
STI
45
26
CVS
41
-4
ECL
55
-2
Financhill
Back

VanEck Natural Resources ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
36

HAP
VanEck Natural Resources ETF

Last Price:
49.44
Seasonality Move:
2.24%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
36
VanEck Natural Resources ETF (HAP) is a Sell

Is VanEck Natural Resources ETF a Buy, Sell or Hold?

  • The current VanEck Natural Resources ETF [HAP] share price is $49.39. The Score for HAP is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • HAP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HAP Stock Price Chart

What is VanEck Natural Resources ETF's stock price today?

  • The VanEck Natural Resources ETF share price today is $49.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HAP is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

HAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 34.18 Sell
Chaikin Money Flow: -768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.12 - 52.02) Sell
Bollinger Bands (100): (49.68 - 51.96) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

HAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.07 Sell
20-day SMA: 50.83 Sell
50-day SMA: 51.35 Sell
200-day SMA: 50.44 Sell
8-day EMA: 49.88 Sell
20-day EMA: 50.6 Sell
50-day EMA: 51.01 Sell
200-day EMA: 50.47 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

VanEck Natural Resources ETF Earnings Growth & HAP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

VanEck Natural Resources ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):